Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.63B
+32.2% from 2023
Prescriptions
96K
$16,878.65 per claim
Patients
12K
6,481 prescribers
Total spending, 2024
$1.63B
$131,536.72 per patient
Medicare prescription drug plans paid $1.63B for Tagrisso in 2024, for 96,370 prescriptions and refills to 12,366 patients (up 32.2% from 2023). The average cost per claim was $16,878.65.
California had the highest Medicare cost for Tagrisso in 2024: $359.9M for 21,332 claims, followed by New York ($192.3M).
Cathleen P Power, nurse practitioner in Boston, MA, had the highest Medicare cost for Tagrisso in 2024: 359 claims costing $6.1M.
Tagrisso is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Cathleen P Power Boston, MA | Nurse Practitioner | 359 | 63 | $6.1M |
| Jason Kao Stanford, CA | Physician Assistant | 348 | 55 | $6.1M |
| Jennifer E Tseng Orlando, FL |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 5,185 | 64,666 | 8,628 | $1.08B |
| 2023 | 5,422 | 70,781 | 9,373 | $1.23B |
| 2024 | 6,481 | 96,370 | 12,366 | $1.63B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 312 |
| 34 |
| $5.1M |
| Jamie E Chaft New York, NY | Medical Oncology | 298 | 40 | $4.9M |
| Judy Y Pagtama Stanford, CA | Nurse Practitioner | 289 | 37 | $4.7M |
| Razmig V Babikian Duarte, CA | Nurse Practitioner | 270 | 33 | $4.4M |
| Mary Carroll Orange, CA | Nurse Practitioner | 242 | 33 | $4.2M |
| Helena Yu New York, NY | Medical Oncology | 241 | 32 | $4.1M |
| Iman Abdalla Los Angeles, CA | Internal Medicine | 231 | 27 | $4.0M |
| Ashish Saxena Flushing, NY | Medical Oncology | 236 | 43 | $3.9M |
| Evan Wu Danville, PA | Medical Oncology | 229 | 32 | $3.9M |
| Kenneth K Ng Rockville Centre, NY | Medical Oncology | 223 | 30 | $3.8M |
| Kimberly N Nojima Chan New York, NY | Nurse Practitioner | 206 | 30 | $3.8M |
| Mark G Kris New York, NY | Medical Oncology | 214 | 26 | $3.6M |
| Hatim Husain San Diego, CA | Hematology-Oncology | 227 | 22 | $3.6M |
| Paul Sadama New York, NY | Nurse Practitioner | 196 | 41 | $3.6M |
| Eddie H Hu Alhambra, CA | Hematology-Oncology | 206 | 25 | $3.4M |
| Shihfan Yeh Vallejo, CA | Hematology-Oncology | 198 | 25 | $3.4M |
| Derek W Shek San Leandro, CA | Medical Oncology | 198 | 23 | $3.4M |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 202 | 37 | $3.3M |
| Siddhartha H Devarakonda Seattle, WA | Medical Oncology | 204 | 31 | $3.3M |
| Lan Mo New York, NY | Hematology-Oncology | 183 | 35 | $3.3M |
| Jessica Ma Fresh Meadows, NY | Nurse Practitioner | 199 | 33 | $3.3M |
| Margaret Arthur Flushing, NY | Nurse Practitioner | 201 | 27 | $3.1M |
| Jonathan W Goldman Santa Monica, CA | Hematology-Oncology | 177 | 21 | $3.0M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 96,403 | $1.63B |